Ethyl Eicosapentanoate and Pharmaceutical Compositions Comprising Ethyl Eicosapentanoate as an Active Ingredient for Use in the Treatment of Non-Alcoholic Steatohepatitis

摘要

Ethyl eicosapentanoate and compositions comprising this compound as an active ingredient for use in the treatment or alleviation of symptoms of non-alcoholic steatohepatitis (NASH) are disclosed.